(Press-News.org) A research team, led by Professor Yongwon Seo in the Graduate School of Carbon Neutrality at UNIST has unveiled a highly efficient method for desalinating seawater using hydrate-based desalination (HBD) technology. The breakthrough is expected to have far-reaching implications for the application of hydrate-based desalination techniques, with the ability to calculate optimal temperatures for enhanced efficiency.
Hydrate desalination technology, known for its eco-friendly freshwater production capabilities, offers a low-energy solution that can be effectively used in treating high concentrations of brine or contaminated water. By leveraging the phenomenon where impurities, including salts, are expelled during the formation of hydrates from brine or contaminated water, clean water can be obtained.
In this study, the research team experimentally measured the thermodynamic properties of cyclopentane hydrate and evaluated the efficiency of the hydrate desalination technique based on these measurements. They also proposed a novel calculation method for predicting the temperature that maximizes desalination efficiency.
“When specific conditions are met after adding cyclopentane, a colorless volatile liquid, to brine, cyclopentane hydrate, consisting of pure water, is formed,” explained Professor Seo. “We experimentally measured the thermodynamic properties of this cyclopentane hydrate to apply it to desalination processes.”
Building upon their experiments, the research team calculated the maximum water yield of cyclopentane hydrate under various conditions. The efficiency was determined based on the maximum water yield and the thermal energy required for cooling during the hydrate desalination process. A thermodynamic relational equation was developed to identify the temperature at which maximum efficiency can be achieved for each brine concentration.
For instance, when the hydrate desalination technique is applied to brine with initial salt concentrations of 3.5 wt% and 5 wt%, the relational equation calculates the energy efficiency optimum temperatures as 273.4 K and 271.5 K, respectively. The corresponding maximum water yields are 67% and 61.1%. This research provides a crucial criterion for optimizing the efficiency of real-world desalination processes.
Junghoon Mok, the first author of the study, emphasized the significance of this research, stating, “This study is expected to optimize the energy consumption in high-concentration brine treatment processes using hydrate freshwater techniques.” He added, “The proposed approach is not only applicable to hydrate-based desalination but also holds promise for freeze-type desalination technology.”
The study was conducted in collaboration with the Korea Institute of Production and Technology and received support from the Ministry of Science and ICT’s Korea Research Foundation’s basic research project, nuclear research and development project, and the Korea Energy Technology Evaluation Institute.
This research, conducted in collaboration with the Korea Institute of Industrial Technology (KITECH), has received support from the Korea Institute of Energy Technology Evaluation and Planning (KETEP), the Ministry of Trade, Industry and Energy (MOTIE), and the National Research Foundation of Korea (NRF). The paper, detailing this groundbreaking research, was published in the November 2023 issue of Water Research.
Journal Reference
Junghoon Mok, Minseo Park, Wonjung Choi, et al., “Investigation of theoretical maximum water yield and efficiency-optimized temperature for cyclopentane hydrate-based desalination,” Water Res., (2023).
END
Breakthrough in hydrate-based desalination technique unveiled
2023-12-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
GFH009: A potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies
2023-12-28
“[...] the results of this preclinical investigation program suggest that induction of apoptosis is a key component of GFH009’s anti-tumor mechanism of action [...]”
BUFFALO, NY- December 28, 2023 – A new research paper was published in Oncotarget's Volume 14 on December 20, 2023, entitled, “The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies.”
To evade cell cycle controls, malignant cells rely upon rapid expression of select proteins to mitigate pro-apoptotic signals ...
Angelica gigas extract inhibits acetylation of eNOS in vascular dysfunction
2023-12-28
“Angelica gigas Nakai (AG), a traditional medicinal herb, is garnering scientific attention for its potential in addressing a variety of health conditions.”
BUFFALO, NY- December 27, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 23, entitled, “Angelica gigas extract inhibits acetylation of eNOS via IRE1α sulfonation/RIDD-SIRT1-mediated posttranslational modification ...
Johns Hopkins researchers: Regret rarer than believed among patients who undergo gender affirming surgery
2023-12-28
FOR IMMEDIATE RELEASE
In a Viewpoint article published Dec. 27, 2023, in JAMA Surgery, three Johns Hopkins researchers urge the medical community to dismiss a widely held, but scientifically unsupported belief that many people who are transgender and gender diverse (TGD), and undergo gender affirming surgery (GAS), later regret their decision to undergo such procedures.
The researchers are:
Harry Barbee, Ph.D., assistant professor and interdisciplinary social scientist at the Johns Hopkins Bloomberg School of Public Health
Bashar ...
Future labor losses due to heat stress in China under climate change scenarios
2023-12-28
Climate change is the biggest global health threat in the 21st century, and the rising temperatures have undermined the health and safety of the working population, as well as caused labor losses, which are closely tied to social-economic development. Although the future temperatures increase in China has been forecasted by state-of-the-art climate change projections, to what extent the influence on labor has not been well studied. In a paper published in Science Bulletin, a Chinese research team presents evidence of future labor losses due to heat stress in China under climate change scenarios. This study was led by Cunrui Huang, a professor at the Vanke School of Public ...
Acellular players in the high cryosphere: diversity, function and activity of the global supraglacial DNA viruses
2023-12-28
Supraglacial environments mainly consist of four main types of habitats for microbes and viruses, including snow, ice, meltwater, and cryoconites (the granular sediment on glacier surfaces). The paper revealed that there were more than 10,000 viral species in global supraglacial environments. This is a 15-fold expansion of DNA viral genomic inventory ever known. These viruses mainly belong to bacteriophages, viruses infecting bacteria. Liu et al., also found the viral communities showed a clear regional and habitat distribution pattern, with polar glacier samples separated from mountain ...
A carbon-lite atmosphere could be a sign of water and life on other terrestrial planets, MIT study finds.
2023-12-28
Scientists at MIT, the University of Birmingham, and elsewhere say that astronomers’ best chance of finding liquid water, and even life on other planets, is to look for the absence, rather than the presence, of a chemical feature in their atmospheres.
The researchers propose that if a terrestrial planet has substantially less carbon dioxide in its atmosphere compared to other planets in the same system, it could be a sign of liquid water — and possibly life — on that planet’s surface.
What’s more, this new signature is within the sights of NASA’s James Webb Space Telescope (JWST). While scientists have proposed ...
Insilico announces the expansion of its oncology pipelines and delivers the new generation FGFR2/3 inhibitor
2023-12-28
- The nomination of the new generation of FGFR2/3 inhibitor for the treatment of tissue-agnostic solid tumors, bringing the total number of PCCs nominated by Insilico in 2023 to six.
- ISM8001 is an oral, highly selective, covalent inhibitor that demonstrated superior potency in multiple FGFR2/3-driven efficacy models, and also in gatekeeper and molecular brake mutant resistant models.
- The program once again demonstrates Insilico's ability to efficiently generate novel molecules with high quality that are currently available for partnering.
Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery ...
Liso-cel is a cost effective second-line treatment for common form of lymphoma
2023-12-28
(WASHINGTON, Dec. 28, 2023) – Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat) diffuse large B-cell lymphoma (r/r DLBCL), according to a study published today in Blood Advances. The study is the first of its kind to incorporate healthcare expenses, societal productivity losses, and patient quality of life in assessing the drug’s cost-effectiveness.
"In our study, we incorporated the often-overlooked societal costs associated with cancer treatment, which are typically neglected in ...
A team from the UPV and CSIC discovers a new method for generating metal nanoparticles for use as catalysts
2023-12-28
This new method is based on the exsolution process activated by microwave radiation. Exsolution is a method of generating metallic nanoparticles on the surface of ceramic materials. "At elevated temperatures and in a reducing atmosphere (usually hydrogen), metal atoms migrate from the structure of the material to its surface, forming metal nanoparticles anchored to the surface. This anchoring significantly increases the strength and stability of these nanoparticles, which positively impacts the efficiency of these catalysts," explains Beatriz García Baños, a researcher in the Microwave Area of the ITACA Institute at the UPV.
In the work now ...
Cancer test shows promise for bringing the benefits of immunotherapy to more patients
2023-12-28
Brigham researchers’ findings from next-generation sequencing suggest that revising current cancer care guidelines could allow approximately 6,000 more patients in the U.S. to benefit from immunotherapy treatment each year
Immunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identifies more cancer patients who could benefit from this form of therapy. Investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, found that nearly six percent of endometrial cancer patients and one percent of colorectal cancer patients with mismatch repair deficiency were ...